白血病抑制因子
外显子
生物
基因
分子生物学
白血病抑制因子受体
基因表达
细胞生物学
遗传学
胚胎干细胞
作者
Bryan P. Haines,Roger B. Voyle,T. A. Pelton,Regan Forrest,Peter D. Rathjen
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:1999-04-15
卷期号:162 (8): 4637-4646
被引量:46
标识
DOI:10.4049/jimmunol.162.8.4637
摘要
Abstract Leukemia inhibitory factor (LIF) is a member of the IL-6 family of pleiotropic cytokines, which are extensively involved in modulating hematopoiesis and immunity. We have undertaken a detailed analysis of LIF genomic organization and gene transcription and investigated the proteins expressed from alternate transcripts. Previously unidentified LIF transcripts, containing alternate first exons spliced onto common second and third exons, were cloned from murine embryonic stem cells, human embryonal carcinoma cells, and primary porcine fibroblasts. Based on sequence homology and position within the genomic sequence, this confirmed the existence of the LIF-M transcript in species other than the mouse and identified a new class of transcript, designated LIF-T. Thus, a complex genomic organization of the LIF gene, conserved among eutherian mammals, results in the expression of three LIF transcripts (LIF-D, LIF-M, and LIF-T) differentially expressed from alternate promoters. The first exon of the LIF-T transcript contained no in-frame AUG, causing translation to initiate downstream of the secretory signal sequence at the first AUG in exon two, producing a truncated LIF protein that was localized within the cell. Enforced secretion of this protein demonstrated that it could act as a LIF receptor agonist. Regulated expression of biologically active intracellular and extracellular LIF cytokine could thus provide alternate mechanisms for the modulation of hematopoiesis and immune system function.
科研通智能强力驱动
Strongly Powered by AbleSci AI